< Back to latest news & events

Event

HGF are Platinum Sponsors of the Dublin IP and R&D Summit

August 2024

HGF is proud to be Platinum sponsors of the IP and R&D Summit, taking place on the 4th and 5th of September 2024. This two day event will be held at the following venues:

Day 1Enterprise Ireland Offices, Ireland 

Day 2The Convention Centre Dublin, Ireland

On day 1, Craig Thomson will be moderating a panel session on: IP Strategy for SMEs and Innovators. This panel will discuss IP strategies for start-ups, focusing on safeguarding ideas and navigating legal complexities.

Panelists:

  • Craig Thomson, Partner & Patent Attorney, HGF
  • Eoin McManus, General Counsel, Klas
  • Pat Fitzgerald, CEO, Beotanics Ltd.
  • Michelle Tierney, Co-Founder & CSO, Mbryonics Ltd.
  • Donal O’Sullivan, CEO, Nutribio

Sean McDonagh will deliver a fireside chat on: Building a Brand Identity for Your Business, alongside Joe Doyle. They will explore how businesses can create and protect strong brand identities.

Sean will also be moderating a panel session on Day 2 of the event, on: Trade Mark Trends – Combating Counterfeiting and Navigating Dispute Resolution. This panel will cover strategies for trade mark protection, dispute resolution, and tackling AI-driven counterfeiting.

Panelists:

  • Sean McDonagh, Trade Mark Director, HGF
  • Ralf Duckeck, VP Intellectual Property, ebm-papst Group
  • Nancy Rowe, Global Head of Trade Marks, Bausch + Lomb
  • Pascal van Troost, Global Intellectual Property Director, Gates
  • Inge Buffollo, Director Business Development, EUIPO

HGF Partners Marie Walsh , Jason Lessard and Andrew McGettrick will also be attending and are looking forward to connecting with industry leaders at the event.

For more details, click the button below.

 

Latest updates

Seminar on Incorporating Trade Secrets into your IP Strategy

HGF is hosting a Seminar on Incorporating Trade Secrets into your IP Strategy which will be followed by networking, apero, and snacks. The Seminar will be held on Wednesday, 10th …

Read article

PRESS RELEASE – HGF strengthens European presence with three new Partners in France and Germany

HGF is pleased to announce the arrival of three new partners, further strengthening its European presence. Two partners will be joining the firm’s fast-growing French practice, and one will join …

Read article

Regulatory Exclusivity for
Medicinal Products in Europe

Video overview: New Medical Products 8 years of data exclusivity, followed by 2 years of market exclusivity. +1 year market exclusivity possible for a new indication showing significant clinical benefit. No exclusivity granted for new formulations or routes of …

Read article

Added Matter - Part 2

Video overview: Pre- and Post-Grant Amendments are governed by Articles 123(2) & 123(3) EPC respectively Before grant, amendments can broaden the claim scope as long as the resulting claim is …

Read article

Added Matter - Part 1

Video overview: What is Added Matter? Added matter occurs when an amendment introduces content that goes beyond what was originally disclosed in the application as filed (Article 123(2) EPC). EPO …

Read article

Patenting Polymorphs at the EPO

Video overview: Novelty and Inventive Step Prior art must necessarily lead to the claimed polymorph to be novelty destroying Watch out for inherent disclosures in prior art—methods may implicitly produce …

Read article

Antibodies

Video overview: EPO Requirements for Antibody Applications The EPO Guidelines (G-II, 6) provide a standardised framework for antibody-related patent issues. Antibodies can be defined by various aspects, including but not …

Read article

Description Amendment Requirements at EPO

Video overview: At the final stage of prosecution, the EPO increasingly insists each patent description must align with the allowed claims to improve clarity and eliminate inconsistencies. However, this strict …

Read article